口腔颌面部腺样囊性癌的治疗--我们的治疗及体会

来源 :2014第八次全国口腔颌面-头颈肿瘤学术研讨会 | 被引量 : 0次 | 上传用户：chywei

【摘要】

：

【作者】

：

席庆张明任仪鹏张蕾梁立民温伟生邵小钧步荣发

【机构】

：

海南省三亚市海棠湾解放军总医院海南分院口腔科 572014 北京复兴路28号解放军总医院口腔颌

【出处】

：

2014第八次全国口腔颌面-头颈肿瘤学术研讨会

【发表日期】

：

2014年3期

【关键词】

：

碘I125 近距离放疗腺样囊性癌口腔

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

目的:探讨手术和125I密封籽源植入治疗口腔颌面部腺样囊性癌的效果.方法:自2006年-2011年234例口腔颌面部腺样囊性癌患者进行了回顾性研究,单纯手术及术后联合普通放疗132例,联合手术及单纯125I密封籽源植入治疗102例,通过临床复诊/影像学检查观察疗效,并观察其并发症.结果:125I密封籽源植入治疗腺样囊性癌,近期有效率(CRPR)高达100％.并发症主要为疼痛/骨髓炎/口内外相通,与手术切除联合术后放疗相比,器官及功能保存有着明显的优势.结论:125I密封籽源植入治疗口腔颌面部腺样囊性癌是一种有效、方便而且副反应小的治疗方法.可以尝试在有限范围内推广及进行大样本多中心的研究.

其他文献

Decreased expression of BATF2 is significantly associated with poor prognosis in oral tongue squamou

BATF2,also called SARI,is associated with several cancer types,and loss of BATF2 expression is frequently detected in aggressive and metastatic cancers.The expression of BATF2 was previously shown to

会议

BATF2tonguesquamous cell carcinomaprognosis

Clinical and prognostic analysis of second primary tongue squamous cell carcinoma after radiotherapy

Objectives:To investigate the clinical characteristics and prognostic factors of post-irradiation tongue squamous cell carcinoma(PTSCC)after definitive radiation for nasopharyngeal carcinoma(NPC)and t

会议

Nasopharyngeal carcinomaRadiotherapySecond primary tumourTongue squamous cell

Selective intra-arterial infusion of rAd-p53 with chemotherapy for advanced oral cancer: a randomize

Background:Combined p53 gene therapy(rAd-p53)and intra-arterial delivery of chemotherapeutic agents for treatment of oral squamous cell carcinoma were evaluated.Methods:Ninety nine patients with stage

会议

Interferon Alfa-2b Adjuvant Therapy Prolongs Survival of Resected Oral Mucosal Malignant Melanoma: A

Objective:Oral mucosal melanoma(OMM)is rare and with poor prognosis.We conducted the study to analyze the therapeutic and adverse effects of high-dose IFN-α-2b(HD-IFN)adjuvant treatment in Chinese pat

会议

oral mucosamalignant melanomahigh-doseinterferon αadjuvant treatment

超声微泡在小鼠颊癌和颈淋巴结转移诊断应用的研究

口腔粘膜暴露于高剂量的致癌物患下可增加患恶性肿瘤的危险性.首先，我们评估了ICR小鼠模型作为颊癌模型的可行性.小鼠接种0.05毫升U14肿瘤细胞悬浮液(1x107/mL)于颊粘膜.组织学染色切片和基因表达分析显示，颊癌和颈淋巴结转移动物模型建立成功.然后探讨造影剂对原发癌和颊癌对局部淋巴结转移的促进作用.淋巴结转移的颊癌小鼠模型建立，然后采用本实验室自制的造影剂给药至脸颊癌并进行成像，观察原发灶和

会议

A modified transcatheter arterial chemoinfusion via the superficial temporal artery in the treatment

Objective:To evaluate the short-and long-term efficacy and side effects of a modified transcatheter arterial chemoinfusion(TACI)via the superficial temporal artery in the treatment of advanced maligna

会议

transcatheter arterial chemoinfusionmaxillamalignant tumorsmodified

以上唇动脉为蒂的逆行鼻唇沟瓣修复鼻眶下区缺损的临床研究

目的：探讨以上唇动脉为蒂的逆行鼻唇沟瓣修复鼻眶下区缺损的手术方法和疗效.方法：2006年9月-2013年5月,收治鼻眶下缺损患者13例.男性9例,女4例；年龄42～78岁,平均年龄57.8岁.所有患者为肿瘤切除术鼻眶下缺损,病程为2月～28年.缺损范围为2.0cm×1.2cm～4.0cm× 3.6cm.术中采用同侧上唇动脉为蒂的逆行鼻唇沟瓣修复缺损,其中10例为带蒂皮瓣,3例为轴型岛状皮瓣；皮瓣切

会议

鼻唇沟皮瓣上唇动脉鼻眶缺损修复

Submandibular gland transfer for prevention of postradiation xerostomia in patients with head and ne

Purpose:To detect the efficacy and safety of submandibular gland transfer for prevention of postradiation xerostomia in patients with head and neck cancer.Materials and Methods:The following data base

会议

Postoperative 125I Brachytherapy Delivered by Digital Model Obturators for Recurrent or Locally Adva

Objective:We aimed to evaluate the feasibility and effectiveness of postoperative 125I brachytherapy delivered by use of digital model obturators for recurrent or locally advanced maxillary cancers.Ma

会议

125I Seed implant brachytherapy for the treatment of parotid gland cancers in children and adolescen

Background and purpose There is a lack of optimal treatment strategies for managing salivary gland cancers in children and adolescents.This study is aimed at assessing the effect of 125I seed implanta

会议

口腔颌面部腺样囊性癌的治疗--我们的治疗及体会

与本文相关的学术论文